Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Leukemia × ponatinib × Clear all

Status

Terminated 3 Completed 3 Withdrawn 1 Unknown 1 Recruiting 1 No longer available 1 Active not recruiting 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1

Interventions

fludarabine phosphate 2 revumenib 1 ponatinib 1 midostaurin 1 fludarabine 1 Whole-Body Irradiation 1 Tacrolimus 1 Mycophenolic Acid 1 Cytarabine 1 Cyclophosphamide 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1 Bone Marrow Transplantation 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01549548 2013-03-15

Compassionate Use Ponatinib

OHSU Knight Cancer Institute

No longer available

MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡